Press "Enter" to skip to content

Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mn

The company’s wholly-owned subsidiary has entered into a stock purchase agreement to acquire 534,194 shares of common stock of biotechnology firm Inipharm Inc USA, for a cash consideration of USD 534.20 per share, Jubilant Life Sciences said in a filing to BSE.

Original source:

Also Read:   Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung